Tilapia Skin Freeze-Dried Biological Dressing Patent
Summary
USPTO granted patent US12589121B2 to Universidade Federal do Ceará for a method of producing freeze-dried tilapia skin biological dressings for wound treatment in humans and animals. The patent covers a multi-step process including cleaning, detergent incubation, bactericidal treatment, detoxifying, antibiotic treatment, freeze-drying, and sterilization. This is a routine patent issuance with no immediate regulatory compliance requirements.
What changed
USPTO granted patent US12589121B2 on March 31, 2026, covering a method for producing occlusive biological dressings from freeze-dried tilapia skin. The process involves cleaning by scraping, washing with saline, incubation with biocompatible detergent and bactericidal agents, detoxifying solution treatment, antibiotic incubation, freezing, cold freeze-drying, vacuum sealing, and sterilization. The patent specifically covers use of tilapia skin to prepare remedies for treating lesions in humans and animals.
This patent grant represents a routine intellectual property issuance with no immediate compliance deadlines. Pharmaceutical companies, medical device manufacturers, and healthcare providers developing biological wound dressings should be aware of this newly granted patent when designing competing products. No action is required for entities not working with tilapia-derived biological dressings.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method for obtaining occlusive biological dressing, occlusive biological dressing, use thereof and kit
Grant US12589121B2 Kind: B2 Mar 31, 2026
Assignee
UNIVERSIDADE FEDERAL DO CEARÁ
Inventors
Manoel Odorico De Moraes Filho, Maria Elisabete Amaral De Moraes, Felipe Augusto Rocha Rodrigues, Carlos Roberto Koscky Paier
Abstract
The present invention describes a method for obtaining freeze-dried tilapia skin, comprising the steps of cleaning by scraping, washing with physiological saline solution and trimming the edges of the skin; incubation with biocompatible detergent in a sterile recipient and rinsing, incubation with bactericidal agent in sterile recipient and rinsing, incubating with detoxifying solution and rinsing, incubation with antibiotics, rinsing and freezing, cold freeze-drying, vacuum sealing and sterilization, and more specifically the present invention includes the use of tilapia skin to prepare a remedy for treating lesions in humans and animals. The present invention relates to the fields of pharmacy, medicine, dentistry, veterinary medicine, chemistry, biotechnology and tissue engineering.
CPC Classifications
A61K 35/60
Filing Date
2019-11-14
Application No.
17294308
Claims
10
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.